Table 2.
Lung cancer incidence during follow-up among current and former smokers in the WIHS and the MACS.
| Baseline | Lung cancer incidence | |||||||
|---|---|---|---|---|---|---|---|---|
| N | % | N | P-yrs | IRper 100,000 |
95% CI | p-value | ||
| Cohort | ||||||||
| WIHS | 2549a | 37 | 37b | 24376 | 151.8 | 106.9 | 209.2 | <0.0001 |
| MACS | 4274 | 63 | 23c | 45362 | 50.7 | 32.1 | 76.1 | |
| HIV status | ||||||||
| Infected | 3735 | 55 | 46 | 38645 | 119.0 | 87.2 | 158.8 | 0.001 |
| Uninfected | 3088 | 45 | 14 | 31093 | 45.0 | 24.6 | 75.6 | |
| Total | 6823 | 100 | 60 | 69738 | 86.0 | 65.7 | 110.7 | |
P-yrs = Person-years; IR = incidence rate; CI = confidence interval.
Excludes 3 WIHS participants with lung cancer diagnosed prior to enrollment.
Includes 31 HIV-infected and 6 HIV-uninfected women.
Includes 15 HIV-infected and 8 HIV-uninfected men.